Summary
According to APO Research, The global Pharmaceutical API and Intermediates market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pharmaceutical API and Intermediates is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pharmaceutical API and Intermediates is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Pharmaceutical API and Intermediates is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Pharmaceutical API and Intermediates is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pharmaceutical API and Intermediates include Lonza, BASF, Patheon, Lianhetech, Jubilant, Catalent, ABA Chem, Actylis and Chiracon, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
In terms of production side, this report researches the Pharmaceutical API and Intermediates production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.
In terms of consumption side, this report focuses on the sales of Pharmaceutical API and Intermediates by region (region level and country level), by company, by type and by application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Pharmaceutical API and Intermediates, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Pharmaceutical API and Intermediates, also provides the consumption of main regions and countries. Of the upcoming market potential for Pharmaceutical API and Intermediates, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmaceutical API and Intermediates sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pharmaceutical API and Intermediates market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pharmaceutical API and Intermediates sales, projected growth trends, production technology, application and end-user industry.
Pharmaceutical API and Intermediates Segment by Company
Lonza
BASF
Patheon
Lianhetech
Jubilant
Catalent
ABA Chem
Actylis
Chiracon
Codexis
CordenPharma
Granules India
Pfizer
Porton
Sanofi
Jiuzhou Pharmaceutical
Menohua
Puluo Pharmaceutical
Stanley
Tianyu shares
Huahai Pharmaceutical
Pharmaceutical API and Intermediates Segment by Type
API
Pharmaceutical Intermediates
Pharmaceutical API and Intermediates Segment by Application
Pharmaceutical
Feed
Food
Cosmetics
Health Products
Pharmaceutical API and Intermediates Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical API and Intermediates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical API and Intermediates and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical API and Intermediates.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pharmaceutical API and Intermediates market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical API and Intermediates industry.
Chapter 3: Detailed analysis of Pharmaceutical API and Intermediates market competition landscape. Including Pharmaceutical API and Intermediates manufacturers' output value, output and average price from 2020 to 2025, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Pharmaceutical API and Intermediates by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Pharmaceutical API and Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
- Market Overview
- Product Definition
- Global Market Growth Prospects
- Global Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2020-2031)
- Global Pharmaceutical API and Intermediates Production Capacity Estimates and Forecasts (2020-2031)
- Global Pharmaceutical API and Intermediates Production Estimates and Forecasts (2020-2031)
- Global Pharmaceutical API and Intermediates Market Average Price (2020-2031)
- Assumptions and Limitations
- Study Goals and Objectives
- Global Pharmaceutical API and Intermediates Market Dynamics
- Pharmaceutical API and Intermediates Industry Trends
- Pharmaceutical API and Intermediates Industry Drivers
- Pharmaceutical API and Intermediates Industry Opportunities and Challenges
- Pharmaceutical API and Intermediates Industry Restraints
- Pharmaceutical API and Intermediates Market by Manufacturers
- Global Pharmaceutical API and Intermediates Production Value by Manufacturers (2020-2025)
- Global Pharmaceutical API and Intermediates Production by Manufacturers (2020-2025)
- Global Pharmaceutical API and Intermediates Average Price by Manufacturers (2020-2025)
- Global Pharmaceutical API and Intermediates Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
- Global Pharmaceutical API and Intermediates Key Manufacturers Manufacturing Sites & Headquarters
- Global Pharmaceutical API and Intermediates Manufacturers, Product Type & Application
- Global Pharmaceutical API and Intermediates Manufacturers Established Date
- Market Competitive Analysis
- Global Pharmaceutical API and Intermediates Market CR5 and HHI
- Global Top 5 and 10 Pharmaceutical API and Intermediates Players Market Share by Production Value in 2024
- 2024 Pharmaceutical API and Intermediates Tier 1, Tier 2, and Tier 3
- Pharmaceutical API and Intermediates Market by Type
- Pharmaceutical API and Intermediates Type Introduction
- API
- Pharmaceutical Intermediates
- Global Pharmaceutical API and Intermediates Production by Type
- Global Pharmaceutical API and Intermediates Production by Type (2020 VS 2024 VS 2031)
- Global Pharmaceutical API and Intermediates Production by Type (2020-2031)
- Global Pharmaceutical API and Intermediates Production Market Share by Type (2020-2031)
- Global Pharmaceutical API and Intermediates Production Value by Type
- Global Pharmaceutical API and Intermediates Production Value by Type (2020 VS 2024 VS 2031)
- Global Pharmaceutical API and Intermediates Production Value by Type (2020-2031)
- Global Pharmaceutical API and Intermediates Production Value Market Share by Type (2020-2031)
- Pharmaceutical API and Intermediates Type Introduction
- Pharmaceutical API and Intermediates Market by Application
- Pharmaceutical API and Intermediates Application Introduction
- Pharmaceutical
- Feed
- Food
- Cosmetics
- Health Products
- Global Pharmaceutical API and Intermediates Production by Application
- Global Pharmaceutical API and Intermediates Production by Application (2020 VS 2024 VS 2031)
- Global Pharmaceutical API and Intermediates Production by Application (2020-2031)
- Global Pharmaceutical API and Intermediates Production Market Share by Application (2020-2031)
- Global Pharmaceutical API and Intermediates Production Value by Application
- Global Pharmaceutical API and Intermediates Production Value by Application (2020 VS 2024 VS 2031)
- Global Pharmaceutical API and Intermediates Production Value by Application (2020-2031)
- Global Pharmaceutical API and Intermediates Production Value Market Share by Application (2020-2031)
- Pharmaceutical API and Intermediates Application Introduction
- Company Profiles
- Lonza
- Lonza Comapny Information
- Lonza Business Overview
- Lonza Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Lonza Pharmaceutical API and Intermediates Product Portfolio
- Lonza Recent Developments
- BASF
- BASF Comapny Information
- BASF Business Overview
- BASF Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- BASF Pharmaceutical API and Intermediates Product Portfolio
- BASF Recent Developments
- Patheon
- Patheon Comapny Information
- Patheon Business Overview
- Patheon Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Patheon Pharmaceutical API and Intermediates Product Portfolio
- Patheon Recent Developments
- Lianhetech
- Lianhetech Comapny Information
- Lianhetech Business Overview
- Lianhetech Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Lianhetech Pharmaceutical API and Intermediates Product Portfolio
- Lianhetech Recent Developments
- Jubilant
- Jubilant Comapny Information
- Jubilant Business Overview
- Jubilant Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Jubilant Pharmaceutical API and Intermediates Product Portfolio
- Jubilant Recent Developments
- Catalent
- Catalent Comapny Information
- Catalent Business Overview
- Catalent Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Catalent Pharmaceutical API and Intermediates Product Portfolio
- Catalent Recent Developments
- ABA Chem
- ABA Chem Comapny Information
- ABA Chem Business Overview
- ABA Chem Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- ABA Chem Pharmaceutical API and Intermediates Product Portfolio
- ABA Chem Recent Developments
- Actylis
- Actylis Comapny Information
- Actylis Business Overview
- Actylis Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Actylis Pharmaceutical API and Intermediates Product Portfolio
- Actylis Recent Developments
- Chiracon
- Chiracon Comapny Information
- Chiracon Business Overview
- Chiracon Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Chiracon Pharmaceutical API and Intermediates Product Portfolio
- Chiracon Recent Developments
- Codexis
- Codexis Comapny Information
- Codexis Business Overview
- Codexis Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Codexis Pharmaceutical API and Intermediates Product Portfolio
- Codexis Recent Developments
- CordenPharma
- CordenPharma Comapny Information
- CordenPharma Business Overview
- CordenPharma Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- CordenPharma Pharmaceutical API and Intermediates Product Portfolio
- CordenPharma Recent Developments
- Granules India
- Granules India Comapny Information
- Granules India Business Overview
- Granules India Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Granules India Pharmaceutical API and Intermediates Product Portfolio
- Granules India Recent Developments
- Pfizer
- Pfizer Comapny Information
- Pfizer Business Overview
- Pfizer Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Pfizer Pharmaceutical API and Intermediates Product Portfolio
- Pfizer Recent Developments
- Porton
- Porton Comapny Information
- Porton Business Overview
- Porton Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Porton Pharmaceutical API and Intermediates Product Portfolio
- Porton Recent Developments
- Sanofi
- Sanofi Comapny Information
- Sanofi Business Overview
- Sanofi Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Sanofi Pharmaceutical API and Intermediates Product Portfolio
- Sanofi Recent Developments
- Jiuzhou Pharmaceutical
- Jiuzhou Pharmaceutical Comapny Information
- Jiuzhou Pharmaceutical Business Overview
- Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio
- Jiuzhou Pharmaceutical Recent Developments
- Menohua
- Menohua Comapny Information
- Menohua Business Overview
- Menohua Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Menohua Pharmaceutical API and Intermediates Product Portfolio
- Menohua Recent Developments
- Puluo Pharmaceutical
- Puluo Pharmaceutical Comapny Information
- Puluo Pharmaceutical Business Overview
- Puluo Pharmaceutical Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Puluo Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio
- Puluo Pharmaceutical Recent Developments
- Stanley
- Stanley Comapny Information
- Stanley Business Overview
- Stanley Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Stanley Pharmaceutical API and Intermediates Product Portfolio
- Stanley Recent Developments
- Tianyu shares
- Tianyu shares Comapny Information
- Tianyu shares Business Overview
- Tianyu shares Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Tianyu shares Pharmaceutical API and Intermediates Product Portfolio
- Tianyu shares Recent Developments
- Huahai Pharmaceutical
- Huahai Pharmaceutical Comapny Information
- Huahai Pharmaceutical Business Overview
- Huahai Pharmaceutical Pharmaceutical API and Intermediates Production, Value and Gross Margin (2020-2025)
- Huahai Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio
- Huahai Pharmaceutical Recent Developments
- Lonza
- Global Pharmaceutical API and Intermediates Production by Region
- Global Pharmaceutical API and Intermediates Production by Region: 2020 VS 2024 VS 2031
- Global Pharmaceutical API and Intermediates Production by Region (2020-2031)
- Global Pharmaceutical API and Intermediates Production by Region: 2020-2025
- Global Pharmaceutical API and Intermediates Production Forecast by Region: 2026-2031
- Global Pharmaceutical API and Intermediates Production by Region: 2020 VS 2024 VS 2031
- Global Pharmaceutical API and Intermediates Production Value by Region (2020-2031)
- Global Pharmaceutical API and Intermediates Production Value by Region: 2020-2025
- Global Pharmaceutical API and Intermediates Production Value by Region (2026-2031)
- Global Pharmaceutical API and Intermediates Market Price Analysis by Region (2020-2031)
- Regional Production Value Trends (2020-2031)
- North America Pharmaceutical API and Intermediates Production Value (2020-2031)
- Europe Pharmaceutical API and Intermediates Production Value (2020-2031)
- Asia-Pacific Pharmaceutical API and Intermediates Production Value (2020-2031)
- South America Pharmaceutical API and Intermediates Production Value (2020-2031)
- Middle East & Africa Pharmaceutical API and Intermediates Production Value (2020-2031)
- Global Pharmaceutical API and Intermediates Consumption by Region
- Global Pharmaceutical API and Intermediates Consumption by Region: 2020 VS 2024 VS 2031
- Global Pharmaceutical API and Intermediates Consumption by Region (2020-2031)
- Global Pharmaceutical API and Intermediates Consumption by Region (2020-2025)
- Global Pharmaceutical API and Intermediates Consumption by Region (2026-2031)
- North America
- North America Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
- North America Pharmaceutical API and Intermediates Consumption by Country (2020-2031)
- U.S.
- Canada
- Mexico
- Europe
- Europe Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
- Europe Pharmaceutical API and Intermediates Consumption by Country (2020-2031)
- Germany
- France
- U.K.
- Italy
- Netherlands
- Asia Pacific
- Asia Pacific Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
- Asia Pacific Pharmaceutical API and Intermediates Consumption by Country (2020-2031)
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- South America
- South America Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
- South America Pharmaceutical API and Intermediates Consumption by Country (2020-2031)
- Brazil
- Argentina
- Chile
- Colombia
- Middle East & Africa
- Middle East & Africa Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
- Middle East & Africa Pharmaceutical API and Intermediates Consumption by Country (2020-2031)
- Egypt
- South Africa
- Israel
- Türkiye
- GCC Countries
- Value Chain and Sales Channels Analysis
- Pharmaceutical API and Intermediates Value Chain Analysis
- Pharmaceutical API and Intermediates Key Raw Materials
- Raw Materials Key Suppliers
- Manufacturing Cost Structure
- Pharmaceutical API and Intermediates Production Mode & Process
- Pharmaceutical API and Intermediates Sales Channels Analysis
- Direct Comparison with Distribution Share
- Pharmaceutical API and Intermediates Distributors
- Pharmaceutical API and Intermediates Customers
- Pharmaceutical API and Intermediates Value Chain Analysis
- Concluding Insights
- Appendix
- Reasons for Doing This Study
- Research Methodology
- Research Process
- Authors List of This Report
- Data Source
- Secondary Sources
- Primary Sources
- Disclaimer
List of Tables
Table 1 | :Pharmaceutical API and Intermediates Industry Trends |
Table 2 | :Pharmaceutical API and Intermediates Industry Drivers |
Table 3 | :Pharmaceutical API and Intermediates Industry Opportunities and Challenges |
Table 4 | :Pharmaceutical API and Intermediates Industry Restraints |
Table 5 | :Global Pharmaceutical API and Intermediates Production Value by Manufacturers (US$ Million) & (2020-2025) |
Table 6 | :Global Pharmaceutical API and Intermediates Production Value Share by Manufacturers (2020-2025) |
Table 7 | :Global Pharmaceutical API and Intermediates Production by Manufacturers (Tons) & (2020-2025) |
Table 8 | :Global Pharmaceutical API and Intermediates Production Market Share by Manufacturers |
Table 9 | :Global Pharmaceutical API and Intermediates Average Price (US$/Ton) of Manufacturers (2020-2025) |
Table 10 | :Global Pharmaceutical API and Intermediates Industry Manufacturers Ranking, 2023 VS 2024 VS 2025 |
Table 11 | :Global Pharmaceutical API and Intermediates Key Manufacturers Manufacturing Sites & Headquarters |
Table 12 | :Global Pharmaceutical API and Intermediates Manufacturers, Product Type & Application |
Table 13 | :Global Pharmaceutical API and Intermediates Manufacturers Established Date |
Table 14 | :Global Manufacturers Market Concentration Ratio (CR5 and HHI) |
Table 15 | :Global Pharmaceutical API and Intermediates by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2024) |
Table 16 | :Major Manufacturers of API |
Table 17 | :Major Manufacturers of Pharmaceutical Intermediates |
Table 18 | :Global Pharmaceutical API and Intermediates Production by Type 2020 VS 2024 VS 2031 (Tons) |
Table 19 | :Global Pharmaceutical API and Intermediates Production by Type (2020-2025) & (Tons) |
Table 20 | :Global Pharmaceutical API and Intermediates Production by Type (2026-2031) & (Tons) |
Table 21 | :Global Pharmaceutical API and Intermediates Production Market Share by Type (2020-2025) |
Table 22 | :Global Pharmaceutical API and Intermediates Production Market Share by Type (2026-2031) |
Table 23 | :Global Pharmaceutical API and Intermediates Production Value by Type 2020 VS 2024 VS 2031 (Tons) |
Table 24 | :Global Pharmaceutical API and Intermediates Production Value by Type (2020-2025) & (Tons) |
Table 25 | :Global Pharmaceutical API and Intermediates Production Value by Type (2026-2031) & (Tons) |
Table 26 | :Global Pharmaceutical API and Intermediates Production Value Market Share by Type (2020-2025) |
Table 27 | :Global Pharmaceutical API and Intermediates Production Value Market Share by Type (2026-2031) |
Table 28 | :Major Manufacturers of Pharmaceutical |
Table 29 | :Major Manufacturers of Feed |
Table 30 | :Major Manufacturers of Food |
Table 31 | :Major Manufacturers of Cosmetics |
Table 32 | :Major Manufacturers of Health Products |
Table 33 | :Global Pharmaceutical API and Intermediates Production by Application 2020 VS 2024 VS 2031 (Tons) |
Table 34 | :Global Pharmaceutical API and Intermediates Production by Application (2020-2025) & (Tons) |
Table 35 | :Global Pharmaceutical API and Intermediates Production by Application (2026-2031) & (Tons) |
Table 36 | :Global Pharmaceutical API and Intermediates Production Market Share by Application (2020-2025) |
Table 37 | :Global Pharmaceutical API and Intermediates Production Market Share by Application (2026-2031) |
Table 38 | :Global Pharmaceutical API and Intermediates Production Value by Application 2020 VS 2024 VS 2031 (Tons) |
Table 39 | :Global Pharmaceutical API and Intermediates Production Value by Application (2020-2025) & (Tons) |
Table 40 | :Global Pharmaceutical API and Intermediates Production Value by Application (2026-2031) & (Tons) |
Table 41 | :Global Pharmaceutical API and Intermediates Production Value Market Share by Application (2020-2025) |
Table 42 | :Global Pharmaceutical API and Intermediates Production Value Market Share by Application (2026-2031) |
Table 43 | :Lonza Company Information |
Table 44 | :Lonza Business Overview |
Table 45 | :Lonza Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 46 | :Lonza Pharmaceutical API and Intermediates Product Portfolio |
Table 47 | :Lonza Recent Development |
Table 48 | :BASF Company Information |
Table 49 | :BASF Business Overview |
Table 50 | :BASF Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 51 | :BASF Pharmaceutical API and Intermediates Product Portfolio |
Table 52 | :BASF Recent Development |
Table 53 | :Patheon Company Information |
Table 54 | :Patheon Business Overview |
Table 55 | :Patheon Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 56 | :Patheon Pharmaceutical API and Intermediates Product Portfolio |
Table 57 | :Patheon Recent Development |
Table 58 | :Lianhetech Company Information |
Table 59 | :Lianhetech Business Overview |
Table 60 | :Lianhetech Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 61 | :Lianhetech Pharmaceutical API and Intermediates Product Portfolio |
Table 62 | :Lianhetech Recent Development |
Table 63 | :Jubilant Company Information |
Table 64 | :Jubilant Business Overview |
Table 65 | :Jubilant Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 66 | :Jubilant Pharmaceutical API and Intermediates Product Portfolio |
Table 67 | :Jubilant Recent Development |
Table 68 | :Catalent Company Information |
Table 69 | :Catalent Business Overview |
Table 70 | :Catalent Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 71 | :Catalent Pharmaceutical API and Intermediates Product Portfolio |
Table 72 | :Catalent Recent Development |
Table 73 | :ABA Chem Company Information |
Table 74 | :ABA Chem Business Overview |
Table 75 | :ABA Chem Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 76 | :ABA Chem Pharmaceutical API and Intermediates Product Portfolio |
Table 77 | :ABA Chem Recent Development |
Table 78 | :Actylis Company Information |
Table 79 | :Actylis Business Overview |
Table 80 | :Actylis Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 81 | :Actylis Pharmaceutical API and Intermediates Product Portfolio |
Table 82 | :Actylis Recent Development |
Table 83 | :Chiracon Company Information |
Table 84 | :Chiracon Business Overview |
Table 85 | :Chiracon Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 86 | :Chiracon Pharmaceutical API and Intermediates Product Portfolio |
Table 87 | :Chiracon Recent Development |
Table 88 | :Codexis Company Information |
Table 89 | :Codexis Business Overview |
Table 90 | :Codexis Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 91 | :Codexis Pharmaceutical API and Intermediates Product Portfolio |
Table 92 | :Codexis Recent Development |
Table 93 | :CordenPharma Company Information |
Table 94 | :CordenPharma Business Overview |
Table 95 | :CordenPharma Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 96 | :CordenPharma Pharmaceutical API and Intermediates Product Portfolio |
Table 97 | :CordenPharma Recent Development |
Table 98 | :Granules India Company Information |
Table 99 | :Granules India Business Overview |
Table 100 | :Granules India Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 101 | :Granules India Pharmaceutical API and Intermediates Product Portfolio |
Table 102 | :Granules India Recent Development |
Table 103 | :Pfizer Company Information |
Table 104 | :Pfizer Business Overview |
Table 105 | :Pfizer Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 106 | :Pfizer Pharmaceutical API and Intermediates Product Portfolio |
Table 107 | :Pfizer Recent Development |
Table 108 | :Porton Company Information |
Table 109 | :Porton Business Overview |
Table 110 | :Porton Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 111 | :Porton Pharmaceutical API and Intermediates Product Portfolio |
Table 112 | :Porton Recent Development |
Table 113 | :Sanofi Company Information |
Table 114 | :Sanofi Business Overview |
Table 115 | :Sanofi Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 116 | :Sanofi Pharmaceutical API and Intermediates Product Portfolio |
Table 117 | :Sanofi Recent Development |
Table 118 | :Jiuzhou Pharmaceutical Company Information |
Table 119 | :Jiuzhou Pharmaceutical Business Overview |
Table 120 | :Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 121 | :Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio |
Table 122 | :Jiuzhou Pharmaceutical Recent Development |
Table 123 | :Menohua Company Information |
Table 124 | :Menohua Business Overview |
Table 125 | :Menohua Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 126 | :Menohua Pharmaceutical API and Intermediates Product Portfolio |
Table 127 | :Menohua Recent Development |
Table 128 | :Puluo Pharmaceutical Company Information |
Table 129 | :Puluo Pharmaceutical Business Overview |
Table 130 | :Puluo Pharmaceutical Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 131 | :Puluo Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio |
Table 132 | :Puluo Pharmaceutical Recent Development |
Table 133 | :Stanley Company Information |
Table 134 | :Stanley Business Overview |
Table 135 | :Stanley Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 136 | :Stanley Pharmaceutical API and Intermediates Product Portfolio |
Table 137 | :Stanley Recent Development |
Table 138 | :Tianyu shares Company Information |
Table 139 | :Tianyu shares Business Overview |
Table 140 | :Tianyu shares Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 141 | :Tianyu shares Pharmaceutical API and Intermediates Product Portfolio |
Table 142 | :Tianyu shares Recent Development |
Table 143 | :Huahai Pharmaceutical Company Information |
Table 144 | :Huahai Pharmaceutical Business Overview |
Table 145 | :Huahai Pharmaceutical Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025) |
Table 146 | :Huahai Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio |
Table 147 | :Huahai Pharmaceutical Recent Development |
Table 148 | :Global Pharmaceutical API and Intermediates Production by Region: 2020 VS 2024 VS 2031 (Tons) |
Table 149 | :Global Pharmaceutical API and Intermediates Production by Region (2020-2025) & (Tons) |
Table 150 | :Global Pharmaceutical API and Intermediates Production Market Share by Region (2020-2025) |
Table 151 | :Global Pharmaceutical API and Intermediates Production Forecast by Region (2026-2031) & (Tons) |
Table 152 | :Global Pharmaceutical API and Intermediates Production Market Share Forecast by Region (2026-2031) |
Table 153 | :Global Pharmaceutical API and Intermediates Production Value Comparison by Region: 2020 VS 2024 VS 2031 (US$ Million) |
Table 154 | :Global Pharmaceutical API and Intermediates Production Value by Region (2020-2025) & (US$ Million) |
Table 155 | :Global Pharmaceutical API and Intermediates Production Value Share by Region (2020-2025) |
Table 156 | :Global Pharmaceutical API and Intermediates Production Value by Region (2026-2031) & (US$ Million) |
Table 157 | :Global Pharmaceutical API and Intermediates Production Value Share by Region: (2026-2031) & (US$ Million) |
Table 158 | :Global Pharmaceutical API and Intermediates Market Average Price (US$/Ton) by Region (2020-2025) |
Table 159 | :Global Pharmaceutical API and Intermediates Market Average Price (US$/Ton) by Region (2026-2031) |
Table 160 | :Global Pharmaceutical API and Intermediates Consumption by Region: 2020 VS 2024 VS 2031 (Tons) |
Table 161 | :Global Pharmaceutical API and Intermediates Consumption by Region (2020-2025) & (Tons) |
Table 162 | :Global Pharmaceutical API and Intermediates Consumption Market Share by Region (2020-2025) |
Table 163 | :Global Pharmaceutical API and Intermediates Consumption Forecasted by Region (2026-2031) & (Tons) |
Table 164 | :Global Pharmaceutical API and Intermediates Consumption Forecasted Market Share by Region (2026-2031) |
Table 165 | :North America Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons) |
Table 166 | :North America Pharmaceutical API and Intermediates Consumption by Country (2020-2025) & (Tons) |
Table 167 | :North America Pharmaceutical API and Intermediates Consumption by Country (2026-2031) & (Tons) |
Table 168 | :Europe Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons) |
Table 169 | :Europe Pharmaceutical API and Intermediates Consumption by Country (2020-2025) & (Tons) |
Table 170 | :Europe Pharmaceutical API and Intermediates Consumption by Country (2026-2031) & (Tons) |
Table 171 | :Asia Pacific Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons) |
Table 172 | :Asia Pacific Pharmaceutical API and Intermediates Consumption by Country (2020-2025) & (Tons) |
Table 173 | :Asia Pacific Pharmaceutical API and Intermediates Consumption by Country (2026-2031) & (Tons) |
Table 174 | :South America Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons) |
Table 175 | :South America Pharmaceutical API and Intermediates Consumption by Country (2020-2025) & (Tons) |
Table 176 | :South America Pharmaceutical API and Intermediates Consumption by Country (2026-2031) & (Tons) |
Table 177 | :Middle East & Africa Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons) |
Table 178 | :Middle East & Africa Pharmaceutical API and Intermediates Consumption by Country (2020-2025) & (Tons) |
Table 179 | :Middle East & Africa Pharmaceutical API and Intermediates Consumption by Country (2026-2031) & (Tons) |
Table 180 | :Key Raw Materials |
Table 181 | :Raw Materials Key Suppliers |
Table 182 | :Pharmaceutical API and Intermediates Distributors List |
Table 183 | :Pharmaceutical API and Intermediates Customers List |
Table 184 | :Research Programs/Design for This Report |
Table 185 | :Authors List of This Report |
Table 186 | :Secondary Sources |
Table 187 | :Primary Sources |
List of Figures
Figure 1 | :Pharmaceutical API and Intermediates Product Image |
Figure 2 | :Global Pharmaceutical API and Intermediates Production Value (US$ Million), 2020 VS 2024 VS 2031 |
Figure 3 | :Global Pharmaceutical API and Intermediates Production Value (2020-2031) & (US$ Million) |
Figure 4 | :Global Pharmaceutical API and Intermediates Production Capacity (2020-2031) & (Tons) |
Figure 5 | :Global Pharmaceutical API and Intermediates Production (2020-2031) & (Tons) |
Figure 6 | :Global Pharmaceutical API and Intermediates Average Price (US$/Ton) & (2020-2031) |
Figure 7 | :Global Top 5 and 10 Pharmaceutical API and Intermediates Players Market Share by Production Value in 2024 |
Figure 8 | :Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024 |
Figure 9 | :API Image |
Figure 10 | :Pharmaceutical Intermediates Image |
Figure 11 | :Global Pharmaceutical API and Intermediates Production by Type (2020 VS 2024 VS 2031) & (Tons) |
Figure 12 | :Global Pharmaceutical API and Intermediates Production Market Share 2020 VS 2024 VS 2031 |
Figure 13 | :Global Pharmaceutical API and Intermediates Production Market Share by Type (2020-2031) |
Figure 14 | :Global Pharmaceutical API and Intermediates Production Value by Type (2020 VS 2024 VS 2031) & (Tons) |
Figure 15 | :Global Pharmaceutical API and Intermediates Production Value Share 2020 VS 2024 VS 2031 |
Figure 16 | :Global Pharmaceutical API and Intermediates Production Value Share by Type (2020-2031) |
Figure 17 | :Pharmaceutical Image |
Figure 18 | :Feed Image |
Figure 19 | :Food Image |
Figure 20 | :Cosmetics Image |
Figure 21 | :Health Products Image |
Figure 22 | :Global Pharmaceutical API and Intermediates Production by Application (2020 VS 2024 VS 2031) & (Tons) |
Figure 23 | :Global Pharmaceutical API and Intermediates Production Market Share 2020 VS 2024 VS 2031 |
Figure 24 | :Global Pharmaceutical API and Intermediates Production Market Share by Application (2020-2031) |
Figure 25 | :Global Pharmaceutical API and Intermediates Production Value by Application (2020 VS 2024 VS 2031) & (Tons) |
Figure 26 | :Global Pharmaceutical API and Intermediates Production Value Share 2020 VS 2024 VS 2031 |
Figure 27 | :Global Pharmaceutical API and Intermediates Production Value Share by Application (2020-2031) |
Figure 28 | :Global Pharmaceutical API and Intermediates Production by Region: 2020 VS 2024 VS 2031 (Tons) |
Figure 29 | :Global Pharmaceutical API and Intermediates Production Market Share by Region: 2020 VS 2024 VS 2031 |
Figure 30 | :Global Pharmaceutical API and Intermediates Production Value Comparison by Region: 2020 VS 2024 VS 2031 (US$ Million) |
Figure 31 | :Global Pharmaceutical API and Intermediates Production Value Share by Region: 2020 VS 2024 VS 2031 |
Figure 32 | :North America Pharmaceutical API and Intermediates Production Value (2020-2031) & (US$ Million) |
Figure 33 | :Europe Pharmaceutical API and Intermediates Production Value (2020-2031) & (US$ Million) |
Figure 34 | :Asia-Pacific Pharmaceutical API and Intermediates Production Value (2020-2031) & (US$ Million) |
Figure 35 | :South America Pharmaceutical API and Intermediates Production Value (2020-2031) & (US$ Million) |
Figure 36 | :Middle East & Africa Pharmaceutical API and Intermediates Production Value (2020-2031) & (US$ Million) |
Figure 37 | :North America Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 38 | :North America Pharmaceutical API and Intermediates Consumption Market Share by Country (2020-2031) |
Figure 39 | :U.S. Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 40 | :Canada Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 41 | :Mexico Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 42 | :Europe Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 43 | :Europe Pharmaceutical API and Intermediates Consumption Market Share by Country (2020-2031) |
Figure 44 | :Germany Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 45 | :France Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 46 | :U.K. Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 47 | :Italy Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 48 | :Netherlands Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 49 | :Asia Pacific Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 50 | :Asia Pacific Pharmaceutical API and Intermediates Consumption Market Share by Country (2020-2031) |
Figure 51 | :China Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 52 | :Japan Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 53 | :South Korea Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 54 | :Southeast Asia Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 55 | :India Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 56 | :Australia Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 57 | :South America Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 58 | :South America Pharmaceutical API and Intermediates Consumption Market Share by Country (2020-2031) |
Figure 59 | :Brazil Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 60 | :Argentina Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 61 | :Chile Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 62 | :Middle East & Africa Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 63 | :Middle East & Africa Pharmaceutical API and Intermediates Consumption Market Share by Country (2020-2031) |
Figure 64 | :Egypt Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 65 | :South Africa Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 66 | :Israel Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 67 | :Türkiye Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 68 | :GCC Countries Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons) |
Figure 69 | :Pharmaceutical API and Intermediates Value Chain |
Figure 70 | :Manufacturing Cost Structure |
Figure 71 | :Pharmaceutical API and Intermediates Production Mode & Process |
Figure 72 | :Direct Comparison with Distribution Share |
Figure 73 | :Distributors Profiles |
Figure 74 | :Years Considered |
Figure 75 | :Research Process |
Figure 76 | :Key Executives Interviewed |
Request a Sample
Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Chemical & Material
Global Pharmaceutical API and Intermediates Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
Pages: 192
Complete Your Request
Customer reviews
- 0 out of 5
- 0 Reviews
5
4
3
2
1
No Rating Review Exist.
Write Review
Suggested Report
View MoreNo data found.